All Pathways
Colorectal SurgeryEmergency

Acute Colonic Pseudo-Obstruction (Ogilvie's Syndrome) Management (ASCRS 2016)

Acute Colonic Pseudo-Obstruction (Ogilvie's Syndrome) Management (ASCRS 2016): Suspected Ogilvie's Syndrome (ACPO) → Clinical Presentation → Diagnostic ...

Interactive Decision Tree

Mini Map

Algorithm Steps

  1. Start

    Suspected Ogilvie's Syndrome (ACPO)

    Colonic dilation without mechanical obstruction

    1. Action

      Clinical Presentation

      Typical features and risk factors

      • Massive abdominal distension
      • Absent or minimal pain (unless ischemia)
      • Nausea, vomiting
      • Obstipation (may still pass flatus)
      • RISK FACTORS:
      • - Post-operative (orthopedic, cardiac, spinal)
      • - Critical illness, sepsis
      • - Medications (opioids, anticholinergics)
      • - Electrolyte abnormalities
      • - Neurologic conditions
      1. Action

        Diagnostic Workup

        Exclude mechanical obstruction

        • CT abdomen/pelvis WITH contrast
        • Must rule out mechanical obstruction
        • Assess for: Transition point, mass, volvulus
        • Measure cecal diameter (critical)
        • Labs: Electrolytes (K, Mg, Ca), CBC
        • Water-soluble contrast enema if CT unclear
        1. Decision

          Signs of Perforation/Ischemia?

          Emergency surgery if present

          • Peritonitis
          • Free air
          • Cecal pneumatosis
          • Severe localized pain
          1. Warning

            EMERGENCY SURGERY

            Perforation or ischemia

            • Exploratory laparotomy
            • Right hemicolectomy if ischemic cecum
            • Subtotal colectomy if extensive
            • Primary anastomosis vs ileostomy
            • Mortality 30-50% with perforation
            1. Action

              Post-Treatment Care

              Prevent recurrence

              • Advance diet slowly
              • Continue bowel regimen
              • Mobilize patient
              • Monitor for recurrence (10-30%)
              • Address underlying cause
              • Repeat neostigmine if recurs
              1. Outcome

                Outcomes

                Prognosis

                • Overall mortality: 15-30%
                • With perforation: 30-50%
                • Recurrence: 10-30%
                • Most respond to conservative + neostigmine
          2. Decision

            Cecal Diameter Assessment

            Determines urgency of intervention

            • HIGH RISK: >12cm or >9cm for >3 days
            • Perforation risk increases significantly
            1. Action

              Conservative Management

              For cecum <12cm, <3 days duration

              • NPO, NG tube if vomiting
              • IV fluids, correct electrolytes
              • Discontinue opioids/anticholinergics
              • Mobilize patient if possible
              • Rectal tube (limited benefit)
              • Knee-chest position intermittently
              • Daily abdominal X-rays
              • Trial for 24-48 hours
              1. Decision

                Response to Conservative Rx?

                Reassess at 24-48 hours

                1. Action

                  Neostigmine Administration

                  Pharmacologic decompression

                  • DOSE: 2mg IV over 3-5 minutes
                  • MONITORING: Continuous cardiac (bradycardia risk)
                  • Atropine at bedside
                  • CONTRAINDICATIONS:
                  • - Recent MI
                  • - Bradycardia <60
                  • - Active bronchospasm
                  • - Mechanical obstruction not excluded
                  • Response expected within 30 min
                  • Can repeat once if partial response
                  1. Decision

                    Response to Neostigmine?

                    Assess clinical/radiographic improvement

                    • Success: 80-90%
                    • Decompression within 30 min
                    • May repeat once if partial response
                    1. Action

                      Colonoscopic Decompression

                      If neostigmine fails or contraindicated

                      • Minimal insufflation
                      • Decompress to hepatic flexure
                      • Place decompression tube
                      • Suction as advancing
                      • Success rate: 70-80%
                      • Recurrence: 10-30%
                      • Risk: Perforation 1-3%
                      1. Decision

                        Decompression Successful?

                        Assess need for surgery

                        1. Action

                          Surgical Intervention

                          For refractory cases

                          • CECOSTOMY: Percutaneous or surgical
                          • Decompresses without resection
                          • For poor surgical candidates
                          • RESECTION: If ischemia/perforation
                          • Ileostomy vs anastomosis based on status

Guideline Source

ASCRS Clinical Practice Guidelines for Acute Colonic Pseudo-Obstruction

Clinical Safety Information

Clinical Decision Support — Not a Substitute for Clinical Judgment

Individual patient factors may require deviation from these recommendations.

Known Limitations

  • Neostigmine contraindicated with cardiac conditions
  • Requires cardiac monitoring
  • Multiple etiologies may coexist
  • Recurrence common

Applicable Regions

USEU
Version 1Next review: 2027-01-11

Frequently Asked Questions

What is the Acute Colonic Pseudo-Obstruction (Ogilvie's Syndrome) Management (ASCRS 2016)?

The Acute Colonic Pseudo-Obstruction (Ogilvie's Syndrome) Management (ASCRS 2016) is a emergency clinical algorithm for Colorectal Surgery. It provides a structured decision tree to guide clinical decision-making, based on ASCRS Clinical Practice Guidelines for Acute Colonic Pseudo-Obstruction.

What guideline is the Acute Colonic Pseudo-Obstruction (Ogilvie's Syndrome) Management (ASCRS 2016) based on?

This algorithm is based on ASCRS Clinical Practice Guidelines for Acute Colonic Pseudo-Obstruction (DOI: 10.1097/DCR.0000000000000489).

What are the limitations of the Acute Colonic Pseudo-Obstruction (Ogilvie's Syndrome) Management (ASCRS 2016)?

Known limitations include: Neostigmine contraindicated with cardiac conditions; Requires cardiac monitoring; Multiple etiologies may coexist; Recurrence common. Individual patient factors may require deviation from these recommendations.

Get AI-Powered Analysis Alongside This Algorithm

In AttendMe.ai, the Acute Colonic Pseudo-Obstruction (Ogilvie's Syndrome) Management (ASCRS 2016) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.

Try AttendMe Free